DrugCite
Search

BLOPRESS TABLETS

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Blopress Tablets Adverse Events Reported to the FDA Over Time

How are Blopress Tablets adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Blopress Tablets, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Blopress Tablets is flagged as the suspect drug causing the adverse event.

Most Common Blopress Tablets Adverse Events Reported to the FDA

What are the most common Blopress Tablets adverse events reported to the FDA?

Interstitial Lung Disease
44 (5.86%)
Rhabdomyolysis
33 (4.39%)
Shock
20 (2.66%)
Loss Of Consciousness
17 (2.26%)
Blood Pressure Decreased
15 (2%)
Intentional Overdose
15 (2%)
Bradycardia
13 (1.73%)
Hypoglycaemia
13 (1.73%)
Liver Disorder
13 (1.73%)
Hypokalaemia
12 (1.6%)
Malaise
12 (1.6%)
Show More Show More
Cerebral Infarction
11 (1.46%)
Renal Failure Acute
11 (1.46%)
Depressed Level Of Consciousness
10 (1.33%)
Pyrexia
9 (1.2%)
Dehydration
8 (1.07%)
Platelet Count Decreased
8 (1.07%)
Hepatic Function Abnormal
7 (.93%)
Hyperkalaemia
7 (.93%)
Alanine Aminotransferase Increased
6 (.8%)
Aspartate Aminotransferase Increase...
6 (.8%)
Blood Alkaline Phosphatase Increase...
6 (.8%)
Cold Sweat
6 (.8%)
Laryngeal Oedema
6 (.8%)
Lymphocyte Stimulation Test Positiv...
6 (.8%)
Neonatal Hypotension
6 (.8%)
Overdose
6 (.8%)
Blood Lactate Dehydrogenase Increas...
5 (.67%)
Drug Exposure During Pregnancy
5 (.67%)
Dyspnoea
5 (.67%)
Hypoxia
5 (.67%)
Idiopathic Thrombocytopenic Purpura
5 (.67%)
Renal Failure Neonatal
5 (.67%)
Somnolence
5 (.67%)
White Blood Cell Count Increased
5 (.67%)
Acute Generalised Exanthematous Pus...
4 (.53%)
Atrial Fibrillation
4 (.53%)
Blood Glucose Increased
4 (.53%)
Blood Pressure Increased
4 (.53%)
Decreased Appetite
4 (.53%)
Dizziness
4 (.53%)
Electrocardiogram Qt Prolonged
4 (.53%)
Gamma-glutamyltransferase Increased
4 (.53%)
Henoch-schonlein Purpura
4 (.53%)
Hyperhidrosis
4 (.53%)
Multiple Drug Overdose Intentional
4 (.53%)
Pneumonia Bacterial
4 (.53%)
Premature Baby
4 (.53%)
Pulmonary Hypoplasia
4 (.53%)
Renal Failure
4 (.53%)
Shock Haemorrhagic
4 (.53%)
Stevens-johnson Syndrome
4 (.53%)
Vomiting
4 (.53%)
Weight Decreased
4 (.53%)
Atelectasis
3 (.4%)
Cardiac Arrest
3 (.4%)
Cerebellar Infarction
3 (.4%)
Convulsion
3 (.4%)
Death
3 (.4%)
Feeling Abnormal
3 (.4%)
Hepatic Neoplasm Malignant
3 (.4%)
Hypertension
3 (.4%)
Hyperuricaemia
3 (.4%)
Hypocalcaemia
3 (.4%)
Hypotension
3 (.4%)
Jaundice
3 (.4%)
Normochromic Normocytic Anaemia
3 (.4%)
Oedema Peripheral
3 (.4%)
Oligohydramnios
3 (.4%)
Pain In Extremity
3 (.4%)
Palpitations
3 (.4%)
Pancreatitis
3 (.4%)
Proteinuria
3 (.4%)
Pruritus Generalised
3 (.4%)
Sick Sinus Syndrome
3 (.4%)
Suicide Attempt
3 (.4%)
Acute Respiratory Failure
2 (.27%)
Agranulocytosis
2 (.27%)
Ammonia Increased
2 (.27%)
Anaemia
2 (.27%)
Anaphylactic Reaction
2 (.27%)
Atrioventricular Block
2 (.27%)
Blood Creatinine Increased
2 (.27%)
Blood Pressure Systolic Increased
2 (.27%)
Bradyarrhythmia
2 (.27%)
Bronchitis
2 (.27%)
C-reactive Protein Increased
2 (.27%)
Cardiac Failure Acute
2 (.27%)
Cholangitis Suppurative
2 (.27%)
Confusional State
2 (.27%)
Coronary Artery Disease
2 (.27%)
Dialysis
2 (.27%)
Drug Eruption
2 (.27%)
Drug Ineffective
2 (.27%)
Dysphagia
2 (.27%)
Dyspnoea Exertional
2 (.27%)
Embolic Stroke
2 (.27%)
Epistaxis
2 (.27%)
Erythema Multiforme
2 (.27%)
Faecal Incontinence
2 (.27%)
Failure To Thrive
2 (.27%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Blopress Tablets, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Blopress Tablets is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Blopress Tablets

What are the most common Blopress Tablets adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Blopress Tablets, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Blopress Tablets is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Blopress Tablets According to Those Reporting Adverse Events

Why are people taking Blopress Tablets, according to those reporting adverse events to the FDA?

Hypertension
208
Cardiac Failure Chronic
13
Cardiac Failure
8
Drug Exposure During Pregnancy
5
Pregnancy Induced Hypertension
3
Intentional Overdose
2
Show More Show More
Essential Hypertension
2
Product Used For Unknown Indication
1
Migraine
1
Congestive Cardiomyopathy
1
Accidental Exposure
1

Blopress Tablets Case Reports

What Blopress Tablets safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Blopress Tablets. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Blopress Tablets.